Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 152

1.

Human 6-sulfo LacNAc (slan) dendritic cells have molecular and functional features of an important pro-inflammatory cell type in lupus erythematosus.

Hänsel A, Günther C, Baran W, Bidier M, Lorenz HM, Schmitz M, Bachmann M, Döbel T, Enk AH, Schäkel K.

J Autoimmun. 2013 Feb;40:1-8. doi: 10.1016/j.jaut.2012.07.005. Epub 2012 Aug 11.

PMID:
22890025
2.

Reduction of inflammatory slan (6-sulfo LacNAc) dendritic cells in psoriatic skin of patients treated with etanercept.

Günther C, Blau K, Förster U, Viehweg A, Wozel G, Schäkel K.

Exp Dermatol. 2013 Aug;22(8):535-40. doi: 10.1111/exd.12190.

PMID:
23879812
3.

Infliximab induces downregulation of the IL-12/IL-23 axis in 6-sulfo-LacNac (slan)+ dendritic cells and macrophages.

Brunner PM, Koszik F, Reininger B, Kalb ML, Bauer W, Stingl G.

J Allergy Clin Immunol. 2013 Nov;132(5):1184-1193.e8. doi: 10.1016/j.jaci.2013.05.036. Epub 2013 Jul 26.

PMID:
23890755
4.

The phosphodiesterase 4 inhibitor apremilast inhibits Th1 but promotes Th17 responses induced by 6-sulfo LacNAc (slan) dendritic cells.

Oehrl S, Prakash H, Ebling A, Trenkler N, Wölbing P, Kunze A, Döbel T, Schmitz M, Enk A, Schäkel K.

J Dermatol Sci. 2017 Aug;87(2):110-115. doi: 10.1016/j.jdermsci.2017.04.005. Epub 2017 Apr 20.

PMID:
28499587
5.

Human 6-sulfo LacNAc (slan) dendritic cells are a major population of dermal dendritic cells in steady state and inflammation.

Günther C, Starke J, Zimmermann N, Schäkel K.

Clin Exp Dermatol. 2012 Mar;37(2):169-76. doi: 10.1111/j.1365-2230.2011.04213.x. Epub 2011 Dec 20.

PMID:
22188261
6.

[The role of human 6-sulfo LacNAc dendritic cells (slanDCs) in autoimmunity and tumor diseases].

Döbel T, Schäkel K.

J Dtsch Dermatol Ges. 2014 Oct;12(10):874-80. doi: 10.1111/ddg.12439_suppl. Review. German.

PMID:
25262889
7.

G-CSF mobilizes slanDCs (6-sulfo LacNAc+ dendritic cells) with a high proinflammatory capacity.

Baumeister SH, Hölig K, Bornhäuser M, Meurer M, Rieber EP, Schäkel K.

Blood. 2007 Oct 15;110(8):3078-81. Epub 2007 Jul 6. Erratum in: Blood. 2007 Dec 15;110(13):4197.

8.

Reciprocal activating interaction between 6-sulfo LacNAc+ dendritic cells and NK cells.

Wehner R, Löbel B, Bornhäuser M, Schäkel K, Cartellieri M, Bachmann M, Rieber EP, Schmitz M.

Int J Cancer. 2009 Jan 15;124(2):358-66. doi: 10.1002/ijc.23962.

9.

Toll-like receptors 7, 8, and 9 expression and function in primary human cervical cancer Langerhans cells: evidence of anergy.

Kumar MM, Adurthi S, Ramachandran S, Mukherjee G, Joy O, Krishnamurthy H, Krishna S, Bafna UD, Uma DK, Jayshree RS.

Int J Gynecol Cancer. 2013 Jan;23(1):184-92. doi: 10.1097/IGC.0b013e31827a2003.

PMID:
23221735
10.

TNFR2 and IL-12 coactivation enables slanDCs to support NK-cell function via membrane-bound TNF-α.

Tufa DM, Chatterjee D, Low HZ, Schmidt RE, Jacobs R.

Eur J Immunol. 2014 Dec;44(12):3717-28. doi: 10.1002/eji.201444676. Epub 2014 Oct 29.

11.

Reconstitution of 6-sulfo LacNAc dendritic cells after allogeneic stem-cell transplantation.

Mager K, Wehner R, Bahr F, Oelschlägel U, Platzbecker U, Wermke M, Shayegi N, Middeke JM, Radke J, Röllig C, Schetelig J, Thiede C, Ehninger G, Schmitz M, Bornhäuser M, Tuve S.

Transplantation. 2012 Jun 27;93(12):1270-5. doi: 10.1097/TP.0b013e31824fd8b4.

PMID:
22643330
12.

Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8.

Ganguly D, Chamilos G, Lande R, Gregorio J, Meller S, Facchinetti V, Homey B, Barrat FJ, Zal T, Gilliet M.

J Exp Med. 2009 Aug 31;206(9):1983-94. doi: 10.1084/jem.20090480. Epub 2009 Aug 24.

13.

Regulation of intestinal dendritic cell migration and activation by plasmacytoid dendritic cells, TNF-alpha and type 1 IFNs after feeding a TLR7/8 ligand.

Yrlid U, Milling SW, Miller JL, Cartland S, Jenkins CD, MacPherson GG.

J Immunol. 2006 May 1;176(9):5205-12.

14.

Pollen-derived low-molecular weight factors inhibit 6-sulfo LacNAc+ dendritic cells' capacity to induce T-helper type 1 responses.

Gilles S, Jacoby D, Blume C, Mueller MJ, Jakob T, Behrendt H, Schaekel K, Traidl-Hoffmann C.

Clin Exp Allergy. 2010 Feb;40(2):269-78. doi: 10.1111/j.1365-2222.2009.03369.x.

PMID:
20210806
15.

Human dendritic cells stimulated via TLR7 and/or TLR8 induce the sequential production of Il-10, IFN-gamma, and IL-17A by naive CD4+ T cells.

Lombardi V, Van Overtvelt L, Horiot S, Moingeon P.

J Immunol. 2009 Mar 15;182(6):3372-9. doi: 10.4049/jimmunol.0801969.

16.

Short-term cultured, interleukin-15 differentiated dendritic cells have potent immunostimulatory properties.

Anguille S, Smits EL, Cools N, Goossens H, Berneman ZN, Van Tendeloo VF.

J Transl Med. 2009 Dec 18;7:109. doi: 10.1186/1479-5876-7-109.

17.

Controlling the pro-inflammatory function of 6-sulfo LacNAc (slan) dendritic cells with dimethylfumarate.

Oehrl S, Olaru F, Kunze A, Maas M, Pezer S, Schmitz M, Schäkel K.

J Dermatol Sci. 2017 Sep;87(3):278-284. doi: 10.1016/j.jdermsci.2017.06.016. Epub 2017 Jun 24.

PMID:
28732748
18.

A novel modular antigen delivery system for immuno targeting of human 6-sulfo LacNAc-positive blood dendritic cells (SlanDCs).

Bippes CC, Feldmann A, Stamova S, Cartellieri M, Schwarzer A, Wehner R, Schmitz M, Rieber EP, Zhao S, Schäkel K, Temme A, Scofield RH, Kurien BT, Bartsch H, Bachmann M.

PLoS One. 2011 Jan 21;6(1):e16315. doi: 10.1371/journal.pone.0016315.

19.

Increased Numbers of 6-sulfo LacNAc (slan) Dendritic Cells in Hand Transplant Recipients.

Baran W, Koziol M, Woźniak Z, Banasik M, Boratyńska M, Kunze A, Schakel K.

Ann Transplant. 2015 Oct 29;20:649-54.

20.

Synthesis and immunological activities of novel Toll-like receptor 7 and 8 agonists.

Kandimalla ER, Struthers M, Bett AJ, Wisniewski T, Dubey SA, Jiang W, Precopio M, Sun Z, Wang H, Lan T, Agrawal S, Casimiro DR.

Cell Immunol. 2011;270(2):126-34. doi: 10.1016/j.cellimm.2011.03.027. Epub 2011 Apr 22.

PMID:
21570062

Supplemental Content

Support Center